Stock vs Stock Comparison

Centene Corporation vs AbbVie Inc.

ABBV wins the Tale of the Tape 6–3.

CNC$59.99
ABBV$215.40

🏆 Tale of the Tape

36
CNCABBV
-3.4%Profitability (Net Margin)6.9%
Valuation (P/E)106.2x
-11.9%Efficiency (ROIC)8.3%
3/9Health (Piotroski F)7/9
2.7Safety (Altman Z)2.0
19.4%Growth (Rev YoY)8.6%
-0.54Risk (Sharpe 1Y)0.61
2.83xBalance Sheet (D/E)-42.50x
24.27%FCF Yield4.23%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

0.067
252-Day Correlation
-0.001
126-Day Correlation

Low correlation — excellent diversification pair.

Fundamentals

MetricCNCABBV
Market Cap$29.4B$384.7B
P/E Ratio106.2x
Forward P/E13.4x13.4x
P/B1.37x-57.80x
Dividend Yield3.18%
Beta1.060.30

Quantitative Metrics

MetricCNCABBV
DCF Fair Value$149.25$126.26
DCF Upside+298.3%-38.9%
Piotroski F3/97/9
Altman Z2.692.01
Beneish M-3.06-2.87
FCF Yield24.27%4.23%
Net Debt/EBITDA3.0x
ROIC-11.9%8.3%
WACC6.3%7.4%
ROIC – WACC-18.2pp0.8pp
Gross Margin7.1%70.2%
Net Margin-3.4%6.9%
Rev Growth YoY19.4%8.6%
Sharpe (1Y)-0.540.61
Max Drawdown 3Y
FCF Payout Ratio65%

CNC Price

Loading chart...

ABBV Price

Loading chart...

ETF Exposure

CNC found in:

XHS2.90%
XLV0.50%
VHT0.43%
ONEV0.43%
VBR0.30%
VOE0.23%
VFVA0.22%
RSP0.22%
QUS0.19%
VB0.17%
VO0.13%
SPYV0.09%
VONV0.08%
SCHV0.07%
ONEO0.06%
IWD0.05%
VTV0.05%
SPY0.04%
SPTM0.04%
VOO0.04%
VTI0.04%
VONE0.04%
SCHX0.03%
IVV0.03%
SCHB0.03%
ESGV0.03%
SPLG0.03%
ITOT0.03%
URTH0.03%
ACWI0.02%

ABBV found in:

XLV7.07%
IYH6.86%
VHT6.04%
HDV5.61%
SCHD3.53%
DGRO2.52%
DGRW1.99%
MGV1.85%
VIG1.68%
VYM1.56%
NOBL1.49%
VTV1.46%
SDY1.42%
IWF1.39%
SCHV1.38%
VONG1.21%
XBI1.09%
ESGV0.78%
SPYV0.71%
IVV0.69%
SPLG0.68%
SCHX0.66%
SCHB0.62%
ITOT0.61%
VOO0.60%
SPY0.59%
VONE0.57%
SPTM0.55%
VTI0.54%
SPYG0.50%
URTH0.48%
ACWI0.41%
VFVA0.41%
VT0.33%
QUS0.32%
VFMV0.25%
RSP0.19%
ONEO0.03%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

CNC vs ABBV: Head-to-Head Analysis

Centene Corporation (CNC) and AbbVie Inc. (ABBV) represent two companies in the Healthcare sector. In our quantitative Tale of the Tape scoring, ABBV leads 6–3 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, CNC generates a return on invested capital (ROIC) of -11.9% compared to ABBV's 8.3%. This suggests ABBV is more effective at deploying capital to generate shareholder returns.

The 252-day rolling correlation between CNC and ABBV is 0.067, indicating low correlation, making them an effective diversification pair in a portfolio context.

CNC appears in 30 ETFs tracked by SecuritiesDB, while ABBV appears in 38 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, CNC or ABBV?

Our quantitative analysis compares CNC and ABBV across nine fundamental dimensions. ABBV wins the Tale of the Tape 6–3. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are CNC and ABBV correlated?

The 252-day correlation between CNC and ABBV is 0.067. They have low correlation, offering good diversification.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.